# Jazz Pharmaceuticals, Inc. (JAZZ)

Jazz Pharmaceuticals sees a pre-market surge despite an earnings miss, driven by positive trial results for Ziihera and a $200M voucher sale. Social media buzz is up significantly, with creators and mentions increasing.

### About Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. is a pharmaceutical company focused on developing and commercializing medicines.  
Jazz Pharmaceuticals, Inc. uses the ticker $JAZZ for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights
- Jazz Pharmaceuticals, Inc. (JAZZ) social dominance is up 294% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) Galaxy Score™ is up 280% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) creators is up 59.57% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) mentions is up 47.06% from the previous week.
- Jazz Pharmaceuticals, Inc. (JAZZ) posts created is up 57.14% from the previous week.

### Price: $166.30
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/close.tsv)  
The stock price is down -1.79% in the last [--] hours due to an earnings miss and increased competition. However, positive trial results for Ziihera and the sale of a Priority Review Voucher for $200M have caused a pre-market surge, suggesting potential upward momentum.  

24-Hour: -0.47%
7-Day: 0.49%
30-Day: -1.83%

1-Year High: $180.90 on 2025-11-24  
1-Year Low: $97.80 on 2025-05-09  
  
  
### AltRank: [-----]
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/alt_rank.tsv)  
Jazz Pharmaceuticals, Inc. (JAZZ) is currently AltRank #1,162 based on combined combined social and market metrics
Daily Average: [---]  
[--] Week: [-----] +277  
[--] Month: [-----] +285  
[--] Months: [-----] +546  
[--] Year: [-----] +349  
1-Year High: [-----] on 2026-02-04  
1-Year Low: [--] on 2025-07-06  
  
  
### Galaxy Score: [-----]
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/galaxy_score.tsv)  
Current Value: [-----]  
Daily Average: [--]  
[--] Week: [--] +42  
[--] Month: [--] [---]  
[--] Months: [--] +6  
[--] Year: [--] [---]  
1-Year High: [--] on 2025-02-24  
1-Year Low: [--] on 2026-02-09  
  
  
### Engagements: [-----] (24h)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/interactions.tsv)  
Current Value: [-----]  
Daily Average: [------]  
[--] Week: [-----] -29%  
[--] Month: [------] -50%  
[--] Months: [----------] +584%  
[--] Year: [----------] +585%  
1-Year High: [----------] on 2025-11-24  
1-Year Low: [---] on 2025-12-28  

Engagements by network (24h):
X: [-----]
News: [--]
YouTube: [--]
Reddit: [--]
TikTok: [--]

  
  
### Mentions: [--] (24h)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/posts_active.tsv)  
Current Value: [--]  
Daily Average: [--]  
[--] Week: [---] +47%  
[--] Month: [---] -20%  
[--] Months: [-----] -17%  
[--] Year: [-----] +68%  
1-Year High: [---] on 2025-06-17  
1-Year Low: [--] on 2026-01-02  

Mentions by network (24h):
X: [--]
News: [--]
YouTube: [--]
Reddit: [--]
TikTok: [--]

  
  
### Creators: [--] (24h)
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/contributors_active.tsv)  
[--] unique social accounts have posts mentioning Jazz Pharmaceuticals, Inc. (JAZZ) in the last [--] hours which is up 21% from [--] in the previous [--] hours
Daily Average: [--]  
[--] Week: [--] +60%  
[--] Month: [---] -24%  
[--] Months: [-----] -35%  
[--] Year: [-----] +126%  
1-Year High: [---] on 2025-06-28  
1-Year Low: [--] on 2026-01-02  

The most influential creators that mention Jazz Pharmaceuticals, Inc. in the last [--] hours

| Creator                                               | Rank | Followers | Posts | Engagements |
| -------                                               | ---- | --------- | ----- | ----------- |
| [@NightOwlBiotech](/creator/twitter/NightOwlBiotech)  | [--]    | [-----]     | [--]     | [--]          |
| [@BuyTheUgly](/creator/twitter/BuyTheUgly)            | [--]    | [--]        | [--]     | [--]          |
| [@BioPharmCatalyst](/creator/reddit/BioPharmCatalyst) | [--]    | [--]        | [--]     | [--]          |
| [@Kumu88508](/creator/twitter/Kumu88508)              | [--]    | [--]         | [--]     | [--]           |
| [@sarkar32887](/creator/twitter/sarkar32887)          | [--]    | [--]        | [--]     | [--]           |
| [@KallolKalo88348](/creator/twitter/KallolKalo88348)  | [--]    | [--]        | [--]     | [--]           |
| [@Stock_Analysi10](/creator/twitter/Stock_Analysi10)  | [--]    | [--]        | [--]     | [--]           |

[View More](/list/creators/$jazz/100)
  
  
### Sentiment: 43%
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/sentiment.tsv)  
Current Value: 43%  
Daily Average: 80%  
[--] Week: 33% -67%  
[--] Month: 100% +33%  
[--] Months: 100% +22%  
[--] Year: 100% +17%  
1-Year High: 100% on 2025-02-20  
1-Year Low: 35% on 2026-02-15  

Most Supportive Themes:
- Positive Regulatory News and Approvals: (35%) Posts highlight positive regulatory events, such as FDA approvals for generic versions of Jazz Pharmaceuticals' drugs. This theme is supported by the recent FDA approval of the Zepzelca-atezolizumab combination.
- Analyst Recommendations and Price Targets: (25%) Mentions of analyst ratings and price targets, which can influence investor sentiment and trading activity. This is supported by the positive sentiment and high engagement on posts discussing the stock.
- Product Pipeline and Clinical Trials: (20%) Positive mentions of Jazz Pharmaceuticals' product pipeline, including Modeyso (dordavipener) and its inclusion in NCCN guidelines. This is supported by the discussions around the company's future prospects.
  
Most Critical Themes:
- Competition and Market Dynamics: (20%) Mentions of competition in the narcolepsy market, such as Avadel's Lumryz, and the impact on Jazz Pharmaceuticals' market share. This is a concern due to the potential impact on Jazz's revenue.
- Earnings Miss and Financial Performance: (10%) The company faced a miss in earnings expectations, with non-GAAP EPS of $1.68, which could be a concern for investors. This is reflected in the negative price action.
  
  
  
### Social Dominance: 0.00332%
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/social_dominance.tsv)  
Current Value: 0.00332%  
Daily Average: 0.013%  
[--] Week: 0.00394% +0.00294%  
[--] Month: 0.0078% -0.0063%  
[--] Months: 0.0078% -0.0059%  
[--] Year: 0.0078% -0.0054%  
1-Year High: 0.048% on 2025-06-17  
1-Year Low: 0.0022% on 2026-01-02  
  
  
### Market Dominance: 0.011%
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/market_dominance.tsv)  
Current Value: 0.011%  
Daily Average: 0%  
1-Year High: 0.034% on 2025-03-31  
1-Year Low: 0.0083% on 2025-08-06  
  
  
### Market Cap: $10,105,846,442
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$jazz/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$jazz/time-series/market_cap.tsv)  
Current Value: $10,105,846,442  
Daily Average: $8,115,955,358  
[--] Week: $10,105,846,442 +0.49%  
[--] Month: $10,105,846,442 -1.80%  
[--] Months: $10,105,846,442 +40%  
[--] Year: $10,105,846,442 +25%  
1-Year High: $10,992,409,484 on 2025-11-24  
1-Year Low: $6,026,459,193 on 2025-05-09  

### Top Jazz Pharmaceuticals, Inc. Social Posts
Top posts by engagements in the last [--] hours

*Showing a maximum of [--] top social posts without a LunarCrush subscription.*

"# $MSOS https://reuters.com/article/business/healthcare-pharmaceuticals/us-approves-first-marijuana-plant-derived-drug-for-epilepsy-idUSKBN1JL298/ Enough lies. #Cannabis is a medicine. $MSOS $JAZZ U.S. approves first marijuana plant-derived drug for epilepsy https://t.co/qpaK3w1TTG "This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in https://reuters.com/article/business/healthcare-pharmaceuticals/us-approves-first-marijuana-plant-derived-drug-for-epilepsy-idUSKBN1JL298/ Enough lies. #Cannabis is a medicine. $MSOS"  
[X Link](https://x.com/anandamideGreen/status/2023048735178318277) [@anandamideGreen](/creator/x/anandamideGreen) 2026-02-15T14:56Z [----] followers, [----] engagements


"Enough lies. #Cannabis is a medicine. $MSOS $JAZZ U.S. approves first marijuana plant-derived drug for epilepsy "This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies" said Food and Drug Administration Commissioner Scott Gottlieb. https://www.reuters.com/article/business/healthcare-pharmaceuticals/us-approves-first-marijuana-plant-derived-drug-for-epilepsy-idUSKBN1JL298/"  
[X Link](https://x.com/TheMyNotes/status/2022806688240447763) [@TheMyNotes](/creator/x/TheMyNotes) 2026-02-14T22:54Z [----] followers, [----] engagements

Limited data mode. Full metrics available with subscription: lunarcrush.com/pricing